Ami Fadia Analyst PerformanceSr Biotech Equity Research Analyst at Needham & Company LLCAmi Fadia is a stock analyst at Needham & Company LLC, covering 25 publicly traded companies across a range of sectors. Over the past year, Ami Fadia has issued 77 stock ratings, including buy and hold recommendations. While full access to Ami Fadia's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ami Fadia's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings108 Last 9 YearsBuy Recommendations87.74% 93 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution106RatingsDistribution of strong buy, buy, hold, and sell ratings by Ami Fadia.RatingPercentageCount Strong Buy0.0%0 ratings Buy87.7%93 ratings Hold12.3%13 ratings Sell0.0%0 ratingsOut of 106 total stock ratings issued by Ami Fadia at Needham & Company LLC, the majority (87.7%) have been Buy recommendations, followed by 12.3% Hold.Best & Worst CallsBest Call0000.0%AVDLMay 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AMRNDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.0% of companies on NASDAQ24 companiesNYSE4.0% of companies on NYSE1 companyAmi Fadia, an analyst at Needham & Company LLC, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical25 companies100.0%Ami Fadia of Needham & Company LLC specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE17 companies68.0%MED - DRUGS5 companies20.0%PHARMACEUTICAL PREPARATIONS3 companies12.0% About Ami FadiaAmi Fadia joined Needham and Company in May 2021 covering Biotechnology with a focus on targeted oncology and neuroscience. Prior to joining Needham, Ami spent four years as a Managing Director and Senior Analyst at SVB Leerink and previous to that spent six years at UBS where she most recently held the position of Senior Analyst. Ami also spent time working in industry as Head of Strategy & Operations at Sandoz where she was responsible for building a high performing team responsible for strategic planning, sales force strategy, training, project management, budgeting, and business development. Ami began her career in consulting working at KPMG and then McKinsey & Company in their healthcare practice. Ami holds an MBA from the Kellogg School of Management, her Bachelor’s of Commerce from the Shri Ram College, Delhi University and is a member of the Institute of Chartered Accountants of India.Follow on LinkedIn Ami Fadia's Ratings History at Needham & Company LLC Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBIIBBiogen9/4/2025Reiterated Rating$141.62Hold$0.0000.00% ROIJAZZJazz Pharmaceuticals8/28/2025Reiterated Rating$124.43$202.00Buy$0.0000.00% ROIIMRXImmuneering8/26/2025Reiterated Rating$5.95$8.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals8/20/2025Reiterated Rating$119.20$202.00Buy$0.0000.00% ROIRVMDRevolution Medicines8/7/2025Lower Price Target$36.67$56.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals8/6/2025Lower Price Target$6.88$16.00Buy$0.0000.00% ROIMRUSMerus8/6/2025Lower Price Target$67.45$96.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics8/4/2025Reiterated Rating$103.02$150.00Buy$0.0000.00% ROIALKSAlkermes7/29/2025Reiterated Rating$26.15$45.00Buy$0.0000.00% ROIALKSAlkermes7/21/2025Reiterated Rating$29.22$45.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ACADACADIA Pharmaceuticals6/26/2025Reiterated Rating$22.50$30.00Buy$0.0000.00% ROIRVMDRevolution Medicines6/24/2025Reiterated Rating$40.42$57.00Buy$0.0000.00% ROIIMRXImmuneering6/18/2025Reiterated Rating$1.82$9.00Buy$0.0000.00% ROICOGTCogent Biosciences6/17/2025Reiterated Rating$7.49Hold$0.0000.00% ROISAGESage Therapeutics6/16/2025Reiterated Rating$6.70Hold$0.0000.00% ROIPRAXPraxis Precision Medicines6/12/2025Reiterated Rating$44.60$80.00Buy$0.0000.00% ROIBIIBBiogen6/12/2025Reiterated Rating$133.06Hold$0.0000.00% ROIJAZZJazz Pharmaceuticals6/11/2025Reiterated Rating$113.00$202.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics6/9/2025Lower Price Target$111.91$150.00Buy$0.0000.00% ROIIMRXImmuneering6/5/2025Reiterated Rating$1.96$9.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals6/3/2025Reiterated Rating$108.29$202.00Buy$0.0000.00% ROIBPMCBlueprint Medicines6/2/2025Downgrade$101.15$130.00Hold$0.0000.00% ROICNTACentessa Pharmaceuticals5/28/2025Initiated Coverage$12.77$35.00Buy$0.0000.00% ROIALKSAlkermes5/28/2025Initiated Coverage$29.90$45.00Buy$0.0000.00% ROIMRUSMerus5/19/2025Reiterated Rating$41.56$75.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals5/19/2025Boost Price Target$22.26$30.00Buy$0.0000.00% ROINMRANeumora Therapeutics5/13/2025Reiterated Rating$0.72$5.00Buy$0.0000.00% ROIRVMDRevolution Medicines5/8/2025Reiterated Rating$37.66$57.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals5/8/2025Reiterated Rating$9.47$19.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals5/7/2025Lower Price Target$6.99$27.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals5/7/2025Reiterated Rating$111.17$200.00Buy$0.0000.00% ROIHRMYHarmony Biosciences5/6/2025Reiterated Rating$29.96$49.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines5/5/2025Reiterated Rating$40.24$80.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics5/2/2025Reiterated Rating$9.08$29.00Buy$0.0000.00% ROIBPMCBlueprint Medicines4/28/2025Lower Price Target$87.20$130.00Buy$0.0000.00% ROISAGESage Therapeutics4/25/2025Reiterated Rating$7.79Hold$0.0000.00% ROINBIXNeurocrine Biosciences4/15/2025Upgrade$94.89$138.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals4/10/2025Reiterated Rating$110.12$210.00Buy$0.0000.00% ROIIMRXImmuneering4/10/2025Reiterated Rating$1.29$12.00Buy$0.0000.00% ROINMRANeumora Therapeutics4/10/2025Reiterated Rating$0.76$5.00Buy$0.0000.00% ROIMRUSMerus4/9/2025Reiterated Rating$34.89$83.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics4/9/2025Reiterated Rating$6.38$30.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals4/9/2025Reiterated Rating$6.59$19.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals4/8/2025Reiterated Rating$14.61$28.00Buy$0.0000.00% ROIBPMCBlueprint Medicines4/8/2025Reiterated Rating$80.20$133.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines4/8/2025Reiterated Rating$31.53$85.00Buy$0.0000.00% ROIRVMDRevolution Medicines4/8/2025Reiterated Rating$31.40$59.00Buy$0.0000.00% ROIHRMYHarmony Biosciences4/8/2025Reiterated Rating$28.91$50.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics4/1/2025Reiterated Rating$116.63$153.00Buy$0.0000.00% ROIIMRXImmuneering3/21/2025Reiterated Rating$1.65$12.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics3/11/2025Reiterated Rating$9.79$30.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals3/5/2025Reiterated Rating$140.69$210.00Buy$0.0000.00% ROINMRANeumora Therapeutics3/4/2025Reiterated Rating$1.41$5.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines3/3/2025Lower Price Target$38.60$85.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals3/3/2025Reiterated Rating$7.91$19.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics3/3/2025Reiterated Rating$129.15$153.00Buy$0.0000.00% ROIMRUSMerus2/28/2025Lower Price Target$46.22$83.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals2/27/2025Reiterated Rating$18.96$28.00Buy$0.0000.00% ROIRVMDRevolution Medicines2/27/2025Lower Price Target$40.50$59.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals2/26/2025Boost Price Target$139.67$210.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics2/26/2025Reiterated Rating$11.10$30.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals2/26/2025Reiterated Rating$11.82$32.00Buy$0.0000.00% ROIHRMYHarmony Biosciences2/25/2025Reiterated Rating$34.18$50.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics2/19/2025Boost Price Target$128.09$153.00Buy$0.0000.00% ROIHRMYHarmony Biosciences2/19/2025Lower Price Target$36.76$50.00Buy$0.0000.00% ROIBPMCBlueprint Medicines2/13/2025Reiterated Rating$103.56$133.00Buy$0.0000.00% ROISAGESage Therapeutics2/12/2025Reiterated Rating$7.19Hold$0.0000.00% ROIAXSMAxsome Therapeutics2/10/2025Reiterated Rating$131.74$133.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines2/10/2025Reiterated Rating$86.88$150.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences2/7/2025Reiterated Rating$150.51Hold$0.0000.00% ROIIMRXImmuneering2/6/2025Reiterated Rating$2.03$12.00Buy$0.0000.00% ROIBPMCBlueprint Medicines1/13/2025Reiterated Rating$87.43$135.00Buy$0.0000.00% ROIHRMYHarmony Biosciences1/13/2025Reiterated Rating$35.91$52.00Buy$0.0000.00% ROIITCIIntra-Cellular Therapies1/13/2025Reiterated Rating$127.74$100.00Hold$0.0000.00% ROIBCYCBicycle Therapeutics1/13/2025Reiterated Rating$14.75$32.00Buy$0.0000.00% ROIIMRXImmuneering1/13/2025Reiterated Rating$1.99$15.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals1/13/2025Reiterated Rating$11.77$33.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.